Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Revenue

Jeil Pharma Holdings had revenue of 164.70B KRW in the quarter ending June 30, 2026, with 3.08% growth. This brings the company's total for the last twelve months to 630.89B, down -14.26% year-over-year. In the year 2025, Jeil Pharma Holdings had annual revenue of 657.61B, down -15.67%. That makes Jeil Pharma Holdings the 11,509th largest company in the world by revenue and 544th in South Korea.

• Revenue (ttm): 630.89B
• Revenue Growth: -14.26%
• P/S Ratio: 0.18
• Revenue / Employee: 15.39B
• Employees: 41
• Market Cap: 110.53B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Sector 663.20B 97.8%
• Investment Division 14.84B 2.2%

By Geography

Chart

• South Korea 643.12B 94.8%
• Other Areas 19.43B 2.9%
• Japan 15.50B 2.3%

Fiscal year ended Dec 31, 2025 See the full Jeil Pharma Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	657.61B	-122.21B	-15.67%
Dec 31, 2024	779.82B	-24.22B	-3.01%
Dec 31, 2023	804.04B	11.08B	1.40%
Dec 31, 2022	792.96B	30.40B	3.99%
Dec 31, 2021	762.57B	571.30M	0.07%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error